Dr. Phil Dendy (UK, IPEM) 2007

Dr. Phil Dendy, born in Warrington, Lancashire in 1938, graduated in natural sciences and physics from the University of Cambridge in 1963. He worked as a senior assistant and as an assistant director of research in the department of radiotherapeutics at the University of Cambridge between 1965 and 1975. His main interest at that time was in the development of assay methods that could be used to measure the cytotoxic response of human tumour cells in short term culture and he developed methods of tumour cell identification in vitro.
In 1975 he moved to the University of Aberdeen to become a senior lecturer in Medical Physics and in 1980 a reader in Medical Physics. There he provided services in nuclear medicine and radiotherapy for the Grampian Health Board at the Aberdeen Royal Infirmary. Scientifically, he worked on the assessment of the value of new imaging techniques like SPECT. During all that time he was actively engaged in teaching especially on the Aberdeen Masters in Medical Physics.
In 1983 he was appointed chief physicist at the Cambridge Health Authority where he developed the department of Medical Physics and set up research programmes to study mechanisms of ultrasound, to investigate the potential of computer linear accelerators for 3DCRT and to investigate the physical performance of MRI.
Dr Philip Dendy is one of the UK's pre-eminent Medical Physicists. He has made substantial scientific contributions, has Ied an important Medical Physics department and has been President of IPSM, a pre-cursor to IPEM. In addition to this, though, Dr Dendy has been influential in the development of the medical physics profession and in achieving greater recognition in Europe.
Dr. Dendy worked in EFOMP for many years, serving on and chairing the Federation's Education Training and Professional Committee. Here he laid the foundation for EFOMP's register of accredited training schemes, set up the framework of accreditation, and served as its first registrar.
Establishing the accreditation scheme required the vision to see what was required and what would be feasible, and then entailed a huge amount of patient, careful work with the National Member Organisations, setting out to find and develop a common basis, rather than imposing a particular model.
It is hard to overestimate the importance of this work to the profession, particularly when considered alongside his contribution to EFOMPs work with the European Commission leading to the recognition of the Medical Physics Expert in the European Directives.
Philip has also played a leading role in the organisation of EFOMP Summer schools and other training activities for young medical physicists. He has been extremely influential in the successful liaison with
AAPM.
Throughout his commitment to the training and development of medical physicists to the benefit of the profession and to patients is clear. He has spread the word tirelessly helping the smaller, developing NMOs particularly to move forward in this important area in a manner true to EFOMP's founding aims.